|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0035820,
umls-concept:C0087111,
umls-concept:C0138741,
umls-concept:C0205265,
umls-concept:C0205281,
umls-concept:C0220901,
umls-concept:C0700325,
umls-concept:C1273870,
umls-concept:C1441416,
umls-concept:C1704272
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-2-14
|
|
pubmed:abstractText |
To investigate the prognostic role of prostate-specific antigen (PSA) level and prostate volume (PV) for the need for benign prostatic hyperplasia (BPH)-related invasive therapy among patients initially treated with an alpha1-blocker or watchful waiting (WW) in real-life clinical practice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
300-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15708042-Adrenergic alpha-Antagonists,
pubmed-meshheading:15708042-Aged,
pubmed-meshheading:15708042-Biological Markers,
pubmed-meshheading:15708042-Case Management,
pubmed-meshheading:15708042-Follow-Up Studies,
pubmed-meshheading:15708042-Humans,
pubmed-meshheading:15708042-Life Tables,
pubmed-meshheading:15708042-Male,
pubmed-meshheading:15708042-Middle Aged,
pubmed-meshheading:15708042-Organ Size,
pubmed-meshheading:15708042-Prognosis,
pubmed-meshheading:15708042-Proportional Hazards Models,
pubmed-meshheading:15708042-Prostate,
pubmed-meshheading:15708042-Prostate-Specific Antigen,
pubmed-meshheading:15708042-Prostatectomy,
pubmed-meshheading:15708042-Prostatic Hyperplasia,
pubmed-meshheading:15708042-Risk,
pubmed-meshheading:15708042-Urinary Bladder Neck Obstruction,
pubmed-meshheading:15708042-Urinary Retention
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.
|
|
pubmed:affiliation |
Department of Urology, Academic Medical Centre, Amsterdam, The Netherlands. C.A.Mochtar@amc.uva.nl
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
